proxyvotesnow.com

Home › Upcoming votes › Medicus Pharma Ltd.

Medicus Pharma Ltd. Special Meeting December 2, 2026: Proxy Statement and Past Votes

ContestedMerger or special meeting

The deadline as the proxy statement states it: “voting instructions must be received in each case no later than 10:00 a.m. (Eastern Time) on Monday, November 30, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.

Read the proxy statement on EDGAR

What’s on the ballot

Ballot: see the proxy statement. The items on this ballot could not be read from the filing with enough confidence to list them here. Read the proxy statement. This is a contested meeting: the board and the other side each send their own proxy card, and both proxy statements are listed below.

Last year’s official results

From Medicus Pharma Ltd.’s Form 8-K, filed July 23, 2025, for the meeting held July 22, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.

ItemSupport (of votes cast)Reported outcome
1. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the Company's 2025 fiscal year and the aut99.5%Approved
Elect Director: William L. Ashton99.8%Elected
Elect Director: Dr. Raza Bokhari99.8%Elected
Elect Director: Robert J. Ciaruffoli99.8%Elected
Elect Director: Barry Fishman99.8%Elected
Elect Director: Dr. Larry Kaiser99.8%Elected
Elect Director: Dr. Sara R. May99.8%Elected
Elect Director: Hon. Cathy McMorris Rodgers99.8%Elected
Elect Director: Ajay Raju99.8%Elected
3. The proposal to amend Article 3.2 of the Company's by-laws to replace the reference to "10%" with a reference to "33⅓%" to comply with th99.9%Approved
4. In accordance with Nasdaq Listing Rule 5635(d), the issuance, sale and delivery by the Company pursuant to the Standby Equity Purchase Ag99.3%Approved
5. The proposal to amend the Articles to increase the voting threshold required to remove the Chairman of the Board to a vote of at least 7598%Approved

Filings for this meeting

About this page

The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.